Request completed
Thank you for confirming your registration.
You can revoke this at any time via the “unsubscribe” link in every e-mail received.
We will verify your request and – should you fulfill the requirements* – will provide you with the information you requested in due time.
Best regards
Your FCF Team
*All information and market analyses published by FCF are exclusively directed to and for the use by current and potential institutional clients, partners and investors. FCF retains the right to reject your request.
NEWS & PRESS
FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 07/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 07/2024”. The Monitor is a monthly published overview of venture capital trends in
FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 07/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 07/2024”. The Monitor is a monthly published overview of venture capital trends in the
FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 06/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – USA – 06/2024”. The Monitor is a monthly published overview of venture capital trends in
FCF Interest & Corporate Loan Monitor Q1/2024 published
FCF Fox Corporate Finance GmbH is pleased to publish the new “FCF Interest & Corporate Loan Monitor Q1/2024”. FCF regularly conducts comprehensive research regarding the German corporate loan and interest market, based on publically available
FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 06/2024 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 06/2024”. The Monitor is a monthly published overview of venture capital trends in the
